STAT+: The extremism of the FDA’s Marks and Prasad has come with costs
Stat News • 2/26/2026 – 3/5/2026
Summary
No summary yet.
Advertisement
Cluster Activity
1
1
1
2026-02-262026-03-05
Lindy Score Breakdown (V4.2)
1h
Age
1
Sources
from cluster
2
Hours Since Seen
Final Score12/100
CategoryAntiLindy
StatusActive
Recency Multiplier97% (0.5^2/48)
Hero EligibleYes
Story Timeline
- 2026-02-26
- 2026-02-27
- 2026-03-05STAT+: The extremism of the FDA’s Marks and Prasad has come with costs (current)
Score BreakdownRisk 70
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: Breaking news - too recent to assess longevity
Stories gain Lindy status through source reputation, network consensus, and time survival.
Same Story from 3 sources
Breaking Similar stories
STAT+: Trump can’t break free from vaccine politics
Stat News • 1 day ago
STAT+: What does malpractice insurance have to do with AI?
Stat News • 1 day ago
STAT+: CMS halts enrollment in Elevance’s Medicare Advantage plans, citing years of misconduct
Stat News • 2 days ago
STAT+: A new mystery emerges about Epstein’s involvement in Harvard genetics study
Stat News • Today
STAT+: RFK Jr. has wide discretion to choose evidence to support vaccine decisions, DOJ argues
Stat News • Today
STAT+: CMS wants more drugmakers to join Medicaid ‘most-favored nations’ pilot
Stat News • 1 day ago
STAT+: Pharmalittle: We’re reading about Moderna’s $2.25 billion settlement, FDA warning letters, and more
Stat News • 1 day ago
STAT+: Prime Medicine to seek approval for gene editing treatment after two-patient trial
Stat News • 1 day ago
STAT+: FDA warns more telehealth firms about compounded GLP-1s
Stat News • Today
STAT+: HHS starts phasing out Anthropic’s Claude
Stat News • 2 days ago